Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Hanfei Biotechnology, widely known as HF Collagen, is a prominent Chinese biotechnology company specializing in the large-scale manufacture and global export of hydrolyzed collagen peptides and specialty animal proteins. Established in 2005, the company utilizes advanced enzymatic hydrolysis, ultrafiltration, and automated purification platforms to produce high-purity bovine, fish, and chicken collagen for the pharmaceutical, nutraceutical, and cosmetic industries. With an annual production capacity of 15,000 metric tons, Hanfei provides critical ingredients for applications ranging from bone and joint health supplements to advanced wound care and anti-aging skincare. The company is recognized for its commitment to sustainability and bio-efficacy, maintaining international quality certifications such as HACCP, ISO 9001, and HALAL. Its strategic collaborations with global distributors ensure its products are integrated into major healthcare and consumer brands across North America, Europe, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hanfei Biotechnology.